Peter Sandercock And Ist-3
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:12:54
- More information
Informações:
Synopsis
Acute ischemic stroke is a major public health burden and globally a common cause of death and disability
Episodes
-
Peter Sandercock and IST-3
17/08/2010 Duration: 12minAcute ischemic stroke is a major public health burden and globally a common cause of death and disability. Intravenous recombinant tissue plasminogen activator (rt-PA) is approved for use in selected patients with ischemic stroke within 3 hours of symptom onset. The International Stroke Trial or IST-3 seeks to determine whether a wider range of patients may benefit the International Journal of Stroke spoke to chief investigator Dr Peter Sandercock.